Brugada syndrome and vasospasitc angina do coexist: potential clinical importance.
Aizawa
Yoshifusa
Y
Sato
Akinori
A
D000109:Acetylcholine; D000787:Angina Pectoris / Q000209:etiology*; D002037:Bundle-Branch Block / Q000209:etiology; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D002317:Cardiovascular Agents / Q000627:therapeutic use; D003329:Coronary Vasospasm / Q000139:chemically induced / Q000150:complications* / Q000188:drug therapy; D016757:Death, Sudden, Cardiac / Q000209:etiology / Q000517:prevention & control; D017147:Defibrillators, Implantable; D004562:Electrocardiography; D006801:Humans; D017202:Myocardial Ischemia / Q000150:complications* / Q000175:diagnosis / Q000628:therapy; D013575:Syncope / Q000209:etiology; D014693:Ventricular Fibrillation / Q000175:diagnosis / Q000209:etiology* / Q000517:prevention & control / Q000628:therapy
D002121:Calcium Channel Blockers; D002317:Cardiovascular Agents; D000109:Acetylcholine